Listen to this article
Movia Robotics this week launched its TheraPal line of digital health aids for autism spectrum disorders and other intellectual or developmental disabilities.
Movia Robotics, based in Bristol, Connecticut, has launched its TheraPal Progress Tracker, TheraPal Home, and TheraPal Clinical support tools for use at home and in clinicians’ offices. Robotic aids are designed to be used by parents, therapists and other health professionals for the development and learning of people with neurodevelopmental or intellectual problems, according to the company.
Movia’s Robot-Assisted Intervention is a user-friendly digital tool that uses applied behavior analysis and other evidence-based methods with gamification techniques to enable children and the elderly to engage in a wide range of performance activities. life and self-confidence building.
The fully configurable system has modules for cognitive training, communication training, practice and pedagogical learning. It helps individuals understand and practice basic social skills like making eye contact, building confidence, engaging in conversation, and other intellectual skills like reading comprehension, basic math, and learning. learning auditory processing. The robot-assisted intervention sends data to healthcare professionals who can adjust professional therapies as needed.
âBy using robots that engage and interact with children, we can make children with autism respond more easily,â Timothy Gifford, founder of Movia Robotics, said of the technology. âRobots seem friendlier, less critical than human beings; they seem more secure, so children can explore more, develop self-confidence and have more control while learning skills to help them be successful in their daily lives.
Movia Robotics said its TheraPal product line helps neuro-diverse children with an individualized treatment plan. Its TheraPal Progress Tracker is a dat5a medical device system used as an assistive tool for people and clinicians in home care.
“We are dedicated to showing how robotics can improve the lives of people with autism and other special needs, and the launch of our TheraPal is the first step in our commitment to digital health certification from the FDA,” said CEO Jean-Pierre Bolat.
Editor’s Note: This article was republished from sister publication Medical Design & Outsourcing.